We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VIRC:NASDAQVirco Manufacturing Corporation Analysis

Data as of 2026-05-09 - not real-time

$6.06

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Virco’s stock is trading at $6.06, which sits below its 20‑day (6.09) and 50‑day (6.12) moving averages and well under the 200‑day level of $6.93, confirming a bearish technical backdrop. The RSI of 48.9 places the security near the neutral zone, while the MACD histogram is marginally positive, indicating a tentative bullish signal that has not yet overcome the prevailing downtrend. Volume has been shrinking, and the 30‑day volatility of 33% together with a historic max drawdown of nearly 40% underline a high‑risk price environment. Support is identified around $5.42 and resistance near $6.45, suggesting limited upside in the near term unless a catalyst intervenes.
Fundamentally, the company posted a modest net income of $2.6 million on $199.7 million revenue, yielding a profit margin of just 1.3% and an operating margin that remains negative, while operating cash flow and free cash flow are both negative. However, the forward earnings estimate jumps to $1.76 per share, compressing the forward P/E to about 3.4 versus a trailing P/E of 37.9, which signals a potentially large earnings upside. Insider activity has been supportive, with the CEO and other executives buying roughly $100 k of shares over the past month at prices ranging from $5.52 to $6.22. The dividend yield of 1.64% is paid out at a 62% payout ratio, but the negative cash flows raise questions about its sustainability. Overall, the market’s “Extreme Greed” sentiment (Fear‑Greed Index 90.7) and analyst target price of $7 imply about a 15% upside from current levels.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages
  • Decreasing volume and high recent volatility
  • Support level near $5.42 limiting downside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward P/E of ~3.4 indicating strong earnings upside
  • Insider buying signaling confidence
  • Target price of $7 suggesting ~15% upside

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Persistent negative cash flow and high debt‑to‑equity
  • Modest dividend yield with sustainability concerns
  • Cyclical consumer sector exposure

Key Metrics & Analysis

Financial Health

Revenue Growth-8.00%
Profit Margin1.29%
P/E Ratio37.9
ROE2.39%
ROA1.20%
Debt/Equity38.11
P/B Ratio0.9
Op. Cash Flow$-841000
Free Cash Flow$-13459000

Technical Analysis

TrendBearish
RSI48.9
Support$5.42
Resistance$6.45
MA 20$6.09
MA 50$6.12
MA 200$6.93
MACDBullish
VolumeDecreasing
Fear & Greed Index90.73

Valuation

Target Price$7.00
Upside/Downside15.51%
GradeUndervalued
TypeBlend
Dividend Yield1.64%

Risk Assessment

Beta0.81
Volatility33.25%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.